• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Efficacy and Safety of Wuling Powder and Western Medicine in Treatment of Hyperuricemia: A Meta-analysis of Clinical Trials

    2021-10-21 08:53:04QiushuangLIZheLIQingyuXIEKunZHANGGuangRONGPingxinHAN
    Medicinal Plant 2021年4期
    關(guān)鍵詞:痹癥五苓散白虎

    Qiushuang LI, Zhe LI, Qingyu XIE, Kun ZHANG, Guang RONG*, Pingxin HAN

    1. Biomedicine Department of Beijing City University, Beijing 100094, China; 2.Dongzhimen Hospital, Beijing 100700, China; 3. Chengdu Yilian Technology Co., Ltd., Chengdu 610041, China

    Abstract [Objectives] To compare the clinical efficacy and safety of Wuling powder and conventional Western medicine for lowering uric acid in the treatment of hyperuricemia. [Methods] Databases such as CNKI, Wanfang Data, VIP Database, PubMed, Cochrane library and Embase, were retrieved, and comparative experiments of efficacy (serum uric acid level) and safety (incidence of adverse reactions) between Wuling powder (used singly or combined with other prescriptions) and conventional Western medicine in the treatment of hyperuricemia were included, and effect size was pooled with Revman 5.3. [Results] A total of 11 articles, involving 817 patients, were included, and their research quality was evaluated to be low. In terms of overall effect, Wuling powder (used singly or combined with other prescriptions) was better than the control drug in reducing serum uric acid level, but the difference was insignificant [SMD=-0.37, 95% CI (-0.90, 0.16)]. The heterogeneity between studies was high. The incidence of adverse reactions in the experimental group was significantly lower than that in the control group. Subgroup analysis shows that Wuling powder combined with other prescriptions was better than the control drug in reducing serum uric acid level [SMD=-0.37, 95% CI (-0.90, 0.16), P=0.17], and the heterogeneity was reduced. [Conclusions] Wuling powder combined with other prescriptions is better than conventional Western medicine in the treatment of hyperuricemia, and has better safety. Wuling powder alone is not as effective as conventional Western medicine. It is suggested that in clinical work, doctors may need to modify the prescription of Wuling powder. The low quality of the literature supporting this conclusion suggests that this evidence should be interpreted with caution.

    Key words Hyperuricemia, Wuling powder, Meta-analysis

    1 Introduction

    Hyperuricemia (HU) is a pathological state that occurs when the level of serum uric acid (SUA) increases due to abnormal production and/or excretion of SUA, and exceeds a critical value[1]. In recent years, the incidence rate of HU has been increasing in China year by year, 21.7% in men and 8.6% in women, equal to the levels of developed countries[2]. HU is an independent risk factor leading to labor loss. It is also related to the occurrence of atherosclerosis[3], myocardial infarction[4], diabetes[5]and hypertension[6]. HU is a sufficient and non-necessary condition for gout[7]. Among HU patients, 18.8% will progress to gout within five years[8]. The acute onset of gout has a clear causal relationship with SUA level fluctuations[9]. Therefore, controlling the level of SUA is a key for the treatment of gout, and may improve the above-mentioned related diseases or adverse events.

    Conventional urate lowering therapies (ULTs) include allopurinol, benzbromarone and febuxostat. Studies have shown that the SUA-lowering effect of the three is satisfactory. However, allopurinol may cause severe allergic reactions such as Steven-Johnson syndrome and toxic epidermal necrolysis[10].A study[11]has shown that such allergic reactions are closely related to the genotype of commonHLA-B*5801 in Asians. Benzbromarone may also be hepatotoxic[12].Febuxostat can be used in cases of allopurinol allergy and renal insufficiency, but the price is very expensive[13]. Generally, it is only used when the patient cannot tolerate allopurinol[14]. Therefore, research on new methods to reduce SUA has very important clinical and social significance.

    Wuling powder is first recorded inTreatiseonFebrileandMiscellaneousDiseases, and it is widely used in the clinical treatment of HU[15]. Clinical study[16]has found that Wuling powder and its modified prescriptions may have a certain effect in reducing SUA. However, the study has a small sample size and insufficient test power, and the result may be positive due to sampling error. In addition, some patients in the study have differences in baseline disease, and the combination medication situation and medication time of the experimental group are different, making it difficult for clinicians to obtain intuitive conclusions to guide clinical practice. To this end, this research intended to carry out a meta-analysis to explore whether Wuling powder and its modified prescriptions actually have the effect of reducing SUA.

    2 Materials and methods

    2.1 Retrieval strategyThe databases of CNKI, Wanfang Data, VIP Database, PubMed, Embase and Cochrane were retrieved, and the retrieval time was from the establishment of each database to December, 2019. Taking CNKI as an example, the retrieval strategy for Chinese databases was as follows: (AB=痛風(fēng) or AB=痹癥 or AB=痹證 or AB=白虎歷節(jié) or AB=歷節(jié) or AB=高尿酸血癥) and FT=五苓散 and (FT=臨床觀察 or FT=隊(duì)列研究 or FT=療效觀察 or FT=對(duì)照); and taking PubMed as an example, the retrieval strategy for English databases was as follows: 1. exp gout/; 2. hyperuricemia$.tw.; 3. 1 or 2; 4. wu ling san.tw.; 5. wu lingsan.tw.; 6. wulingsan.tw.; 7. wu-ling- san.tw.; 8. $wu-ling-san.tw.; 9. wu-ling-san$.tw.; 10. or/4-9; 11. 3 and 10; 12.randomized controlled trial.pt.; 13. controlled clinical trial.pt.; 14. randomized.ab.; 15. placebo.ab.; 16. drugtherapy.fs.; 17. randomly.ab.; 18. trial.ab.; 19. groups.ab.; 20. or/12-19; 21. (animals not (humans and animals)).sh.; 22. 20 not 21; 23.11 and 22. Other data retrieval was adjusted accordingly.

    2.2 Inclusion and exclusion criteria

    2.2.1Inclusion criteria. (i) Article in which the subject is clearly diagnosed as HU; (ii) Intervention measures: patients in the control group of the article need to use at least one of the urate lowering therapies (alopurinol, benzbromarone and febuxostat), and patients in the treatment group should use Wuling powder singly or in combination with other Chinese medicine prescriptions (Single use of Wuling powder refers to using Wuling powder original prescription or modifying the prescription simply based on TCM syndrome differentiation. Combined use of Wuling powder and other Chinese medicine prescriptions refers to using Wuling powder combined with other prescriptions or Wuling powder-like prescriptions[17], and none Western medicine that has a direct effect on lowering uric acid is taken. If the treatment group and the control group evenly take a certain non-uric acid-lowering drug on the basis of Wuling powder or its combination with other prescriptions as the basic treatment, and the change in the observed effect of the drug is offset between the two groups, the article can be included).(iii) Outcome indicators: the outcome indicators in the article should include at least one of the following indicators, SUA and overall effect. (iv) Control trials that meet the above intervention measures and outcome indicators.

    2.2.2Exclusion criteria. (i) Animal experiments, expert experience, case reports,invitroexperiments,etc.; (ii) Clinical study without a control group; (iii) Clinical research on combined use with other Western medicines except western medicine for lowering uric acid;(iv) Repeated publication; (v) Gout complicated by other diseases; (vi) The outcome indicator of overall effect is mixed with non-SUA evaluation factors, such as the patient’s pain level, and the overall effect cannot be extracted through data processing; (vii) The original research is not standardized and has obvious errors; (viii) Research for which data cannot be extracted; (ix) Non-Chinese and non-English literature.

    2.3 Data extractionTwo reviewers cross-screened the literature, read the titles and abstracts, and excluded articles that did not meet the inclusion criteria. Then, they read through the full text of the articles that might meet the inclusion criteria. The results obtained by the two were checked, and if there was a dispute, a third party was invited to make a ruling.

    2.4 Outcome indicators(i) Main outcome indicator: SUA. (ii) Secondary outcome indicator: overall effect. Article including at least one of the above indicators was included.

    2.5 Quality evaluationAccording to the bias risk evaluation tool of Cochrane Reviewer’s Manual 5.1.0[18], the bias risk of the included studies was evaluated, including (i) whether the method is randomized; (ii) whether the allocation is hidden; (iii) whether there is a reasonable blinding method for participants and implementers; (iv) whether there is a reasonable blinding method for the outcome assessor; (v) whether the result data is incomplete, and whether to conduct loss to follow-up/withdrawal and intention analysis; (vi) whether there is selective reporting bias, and whether to report adverse reactions, uric acid value and other results; (vii) other sources of bias, such as the source of funds. The above items were evaluated by two persons synchronously, and if there was dispute, a third party was invited to make a ruling.

    2.6 Statistics and analysisMeta-analysis of outcome indicators was performed using Revman 5.3. Count data are expressed using relative risk (RR, risk ratio) and 95% confidence interval (95%CI), and measurement data are expressed using standard mean difference (SMD) and 95%CI. A heterogeneity test was performed on the included data. WhenI2≤50%, the heterogeneity is considered acceptable, and the fixed effects model is used; and whenI2>50%, the heterogeneity is considered large, and the random effects model is used[19]. When the random effects model was still highly heterogeneous, subgroup analysis was tried (if the number of articles actually included in a certain index was less than 2, the index would not be subjected to subgroup analysis) to explain the source of heterogeneity. The analysis result is shown in a forest plot. If the number of articles ≥ 10[20], Stata 12.0 was used to draw a funnel chart and perform Egger[21]and Begg[22]tests to quantitatively evaluate publication bias. WhenP≥0.1 in the test result, it is not enough to prove that the research has publication bias[23].

    3 Results and analysis

    3.1 Search resultsAccording to the retrieval strategy, a total of 409 articles were obtained, including 352 articles in CNKI, 49 articles in Wanfang Data, and 8 articles in VIP Database. None related article was retrieved in PubMed, Embase and Cochrane Library. After eliminating 21 duplicate articles and 377 articles based on the reasons in Fig.1, 11 articles were finally included[24-34]. The literature retrieval and screening process is shown in Fig.1.

    Fig.1 Flow chart of literature retrieval

    3.2 Features of included literatureThe basic characteristics of the included literature are shown in Table 1. The included subjects were all clearly diagnosed as HU, and all the literature clearly reported the diagnosis basis. In all the articles, Wuling powder (used singly or in combination with other prescriptions) was used in the experimental group, and conventional Western medicine was used in the control group.

    Table 1 Features of included literature

    3.3 Quality evaluationThe results of the Cochrane systematic review show that the 11 articles[24-34]were all grouped by random methods, random number table method in 2 articles[33-34], numbering-based random grouping in one article[27], admission order-based grouping in one article[25], and simple random methods in the rest articles. None of the articles mentions allocation concealment, one article[29]uses the single-blind method, and one article[32]mentions withdrawal and dropout cases. The methodological characteristics are detailed in Table 2. The evaluation results of the bias risk are shown in Fig.2.

    Fig.2 Analysis results of bias risk of included literature

    Table 2 Methodological quality evaluation of included literature

    3.4 Meta-analysisIn the literature included in this study, the outcome indicators include the SUA level. The evaluation of the overall effect in most of the included literature is based on the evaluation method for the overall effect on gout (GuidingPrinciplesforClinicalResearchofNewDrugs[35-37], which does not list the evaluation method for the overall effect on serum uric acid level), and the indicators also cover non-SUA indicators such as patient’s pain level. We believe that improving the actual symptoms of patients is the focus of clinical research evaluation and should be paid attention to. However, the main purpose of this study is to explore the influence of the experimental drug on the level of SUA, and in the clinic, HU patients are not necessarily accompanied by gout, and patients with gout may also not be accompanied by HU due to good medication control. Therefore, the overall effect reported in these articles was not included in the study.

    ResearcherCochrane systematic reviewRandomizationmethodBlinding methodAllocationconcealmentWithdrawal andloss to follow-upSelectivereportOther biasHao Manxia[28]Only mentioning randomizationNot mentionedNot mentionedUnclearUnclearUnclearWang Fang[29]Random single blind methodSingle blind methodNot mentionedUnclearUnclearUnclearMiao Jun[30]Only mentioning randomizationNot mentionedNot mentionedUnclearUnclearUnclearGuo Guoxing[31]Only mentioning randomizationNot mentionedNot mentionedUnclearUnclearUnclearChen Zhiyan[32]Randomized, controlledNot mentionedNot mentioned2 cases excluded inthe control group;2 cases dropped outin the treatment group UnclearUnclearJin Lanhua[33]Random number tableNot mentionedNot mentionedUnclearUnclearUnclearLi Zhongwan[34]Random number tableNot mentionedNot mentionedUnclearUnclearUnclear

    Taking SUA as the observation index, a heterogeneity test (I2=92%) was performed on the 11 articles, and it is indicated that there is a certain degree of heterogeneity between the studies, so the random effects model is adopted for meta-analysis. The results show thatSMD=-0.37, 95%CI(-0.90, -0.16), andP=0.17, without statistical difference between the two groups, indicating that the treatment group was not evidently better than the control group in reducing SUA level in HU patients, so further subgroup analysis was required (Fig.3).

    Fig.3 SUA forest plot

    3.5 Subgroup analysisThe results of meta-analysis show that the heterogeneity of the research is great, so subgroup analysis was conducted based on the use of Wuling powder alone and in combination with other prescriptions to try to explain the source of heterogeneity.

    3.5.1Subgroup analysis of original prescription and modified prescription of Wuling powder. The treatment groups of total 6 articles[24-25, 28, 32-34]used Wuling powder alone, and the rest 5 articles[26-27, 29-31]used Wuling powder in combination with other Chinese medicines. The results of the SUA subgroup analysis are shown in Fig.4.

    Fig.4 SUA forest plot of subgroups of original and modified prescriptions of Wuling powder

    3.6 Safety analysisA total of 4 articles[26-27, 30, 32]reported adverse reactions, and none of the others reported. The results showed that 1 case of diarrhea occurred in the treatment group, and 16 cases of gastrointestinal reactions, 5 cases of drug intolerance, 3 cases of dizziness, 2 cases of leukopenia, and 1 case of allergic rash appeared in the control group. The incidence of adverse reactions in the treatment group was 0.48% (1/208), and that in the control group was 16.36% (27/165). The difference is statistically significant [RR=0.07, 95%CI(0.02, 0.24),P<0.000 1], indicating the use of Wuling powder combined with other prescriptions to treat HU has a lower incidence of adverse reactions than conventional Western medicines for lowering uric acid (Fig.5).

    Fig.5 Forest plot of adverse reaction incidence

    3.7 Analysis of publication biasThe publication bias of SUA is elucidated using a funnel chart. The results of Egger’s test (t=-0.13,P>0.901) show that there was no significant publication bias (Fig.6), but those of Begg’s test (Z=0.180,P=0.200) show that there was significant publication bias in the SUA level (Fig.7).

    Fig.6 Funnel plot of SUA publication bias

    Note: 1. Wuling powder alone; 2. Original and modified prescriptions of Wuling powder.

    4 Discussion

    A total of 11 articles were included in this study, involving 817 patients. The analysis results show that although the overall effect of Wuling powder (used singly or in combination with other prescriptions) is more effective in reducing patients’ SUA level than conventional uric acid-lowering drugs, but the difference is not statistically significant. What is more, there is great heterogeneity among the studies. Subgroup analysis found that compared with conventional SUA-lowering western medicine, Wuling powder has a better effect in reducing patients’ SUA level when combined with other prescriptions (except for single use), with statistical difference, and the heterogeneity between groups also decreased.

    Existing experimental research shows that Wuling powder should indeed have a certain effect in the treatment of HU, and the main mechanism is to increase the excretion of urine, sodium, urea,etc., similar to that of benzbromarone[38-43]. This study found that the effect of Wuling powder single use subgroup was not better than that of the control drug (the difference from the control drug was not statistically significant,P=0.20), indicating that although Wuling powder alone has no advantage over the control drug, it is at least equivalent in effect, consistent with the finding of the above study that its onset mechanism is similar to western medicine.

    In addition, it was observed that in the subgroup of Wuling powder modified prescriptions, the compatible prescriptions used commonly include Yinchen Wuling powder, Pingwei powder, Simiao powder and Simiao Yongan decoction, and the single herbs used commonly included Herba Artemisiae Capillariae, Rhizoma Atractylodis and Cortex Magnoliae Officinalis. The above-mentioned prescriptions and herbs have all been reported clinically and experimentally, providing evidence for their effectiveness and mechanisms[44-46], and corroborating the results of this study.

    Traditional Western medicines such as allopurinol, febuxostat and benzbromarone have been the basic drugs for the treatment of HU for decades, but a certain amount of adverse events have been reported[47-50]. Traditional Chinese medicine believes that gout-related diseases belong to the categories of "pyretic arthralgia" and "pain arthralgia", and their treatment is based on the principle of "activating blood circulation, relieving pain, promoting urination and excreting dampness"[51]. According toTreatiseonFebrileDiseases, the pathogenesis of the diseases treated with Wuling powder prescription is the abnormal metabolism of fluid in the body, and Wuling powder is a representative prescription for strengthening the spleen, exuding dampness and promoting urination[52]. Pharmacological studies have shown that Wuling powder can increase urine output and increase the excretion of Na+, K+and Cl-in urine, and its diuretic and sodium excretion effect approaches or exceeds that of western diuretics[53]. This is in line with the understanding of Chinese medicine, and is the same as the treatment principle of promoting uric acid excretion in Western medicine. The results of this study show that the incidence of adverse reactions in the Western medicine group was 12.16%, while that in the Wuling powder group was only 1.34%, indicating that Wuling powder has a low incidence of adverse reactions. When Wuling powder is used with allopurinol, in addition to promoting uric acid excretion and inhibiting uric acid production, it is possible to avoid the disadvantages of increased risk of adverse events when two types of Western medicine are used in combination.

    The main advantage of this study is that the experimental groups of all the included articles used Wuling powder alone or in combination with other prescriptions (except conventional Western medicines for lowering uric acid), and the final overall effect is entirely from traditional Chinese medicine. Subgroup analysis was used to compare the effect of Wuling powder used singly or in combination with other traditional Chinese medicines and conventional therapies, and it was found that Wuling powder combined with other traditional Chinese medicines has a significantly better uric acid lowering effect than the control drugs. This provides evidence for how to choose prescriptions and medications for hyperuricemia.

    The meta-analysis in this study has certain limitations, dominated by low methodological quality of the included studies and the small number of included trials. Among the 11 articles, only 4 articles[26-27, 29, 32]describe randomization methods. None of the articles mentioned allocation concealment or blinding. The quality of the research involved in this study is low, so the results may be biased. The included studies have a small sample size, and the systematic error caused by the "small sample research effect" cannot be ruled out[54]. In addition, only 4 of the 11 articles[26-27, 30, 32]described adverse reactions. Due to insufficient description, the count data of adverse reactions is not comprehensive. Therefore, with the development of large-scale, well-designed randomized controlled trials, a more reasonable method is needed to evaluate the adverse reactions and clinical efficacy of Wuling powder. Limited by the number of documents that meet the criteria for inclusion, this study was unable to pass subgroup analysis. Which prescription used in combination with Wuling powder has the best effect needs further study.

    The above results indicate that traditional classic prescriptions can achieve satisfactory results in the treatment of HU when used under the guidance of the theory of syndrome differentiation. Clinically, based on syndrome differentiation, modifying the prescription appropriately may achieve better results. But limited by the number of existing studies, it is yet unable to conduct a sufficient subgroup analysis to distinguish whether this therapeutic advantage comes from other prescriptions used in combination or the interaction between these prescriptions and Wuling powder. Therefore, by combining previous reports and the results of this research, based on the above discussion and analysis, we infer that the effect and mechanism of Wuling powder to reduce SUA should be similar to those of benzbromarone. When combined with other prescriptions with non-diuretic mechanism, a better result will be achieved than Wuling powder alone. In addition, the disadvantage of increased risk of adverse events when two types of Western medicine are used in combination may be avoided.

    5 Conclusions

    Wuling powder combined with other prescriptions is better than conventional Western medicine in treating HU, with good safety. Wuling powder alone is not as effective as conventional Western medicine. In clinical work, doctors may need to modify the prescription of Wuling powder. The low quality of the literature supporting this conclusion suggests that this evidence should be interpreted with caution.

    猜你喜歡
    痹癥五苓散白虎
    從“痹癥有瘀血說(shuō)”論治膝關(guān)節(jié)骨性關(guān)節(jié)炎
    基于數(shù)據(jù)挖掘丹葛五苓散治療CHF作用機(jī)制及實(shí)驗(yàn)驗(yàn)證
    國(guó)醫(yī)大師唐祖宣應(yīng)用五苓散經(jīng)驗(yàn)
    為何說(shuō)西瓜是『天然白虎湯』
    針灸聯(lián)合茵陳五苓散加減治療男性濕熱上蒸型脂溢性脫發(fā)的效果分析
    五苓散治盜汗
    特別健康(2018年4期)2018-07-03 00:38:16
    中藥熏洗治療膝骨性關(guān)節(jié)炎35例臨床觀察
    體、火針結(jié)合治療類風(fēng)濕性關(guān)節(jié)炎42例療效觀察
    白虎
    火花(2015年6期)2015-02-27 07:42:54
    白虎消痤湯加減治療濕熱蘊(yùn)結(jié)型痤瘡47例
    日韩不卡一区二区三区视频在线| 亚洲精品一二三| 99热6这里只有精品| 老司机影院成人| 成人漫画全彩无遮挡| av免费在线看不卡| 日韩三级伦理在线观看| 亚洲欧美精品专区久久| 日本-黄色视频高清免费观看| 日韩视频在线欧美| 国产精品蜜桃在线观看| 狂野欧美激情性bbbbbb| av国产精品久久久久影院| 国产成人免费无遮挡视频| 中国国产av一级| 九色成人免费人妻av| h日本视频在线播放| 99久久精品一区二区三区| 国产久久久一区二区三区| 亚洲精品中文字幕在线视频 | 日韩强制内射视频| 亚洲伊人久久精品综合| 国产午夜精品久久久久久一区二区三区| 黑丝袜美女国产一区| www.av在线官网国产| 免费人成在线观看视频色| av黄色大香蕉| 久久久久久久大尺度免费视频| 美女cb高潮喷水在线观看| 国产黄片视频在线免费观看| 国产精品一区二区在线不卡| 中国三级夫妇交换| 最新中文字幕久久久久| 自拍偷自拍亚洲精品老妇| 插逼视频在线观看| 亚洲在久久综合| 久久精品国产鲁丝片午夜精品| 久久国内精品自在自线图片| 黄色怎么调成土黄色| 精品久久久久久久久av| 一级片'在线观看视频| 少妇人妻 视频| 日韩中字成人| 中文欧美无线码| 国产精品国产三级专区第一集| 老司机影院毛片| 成人美女网站在线观看视频| 亚洲精品456在线播放app| 一本一本综合久久| 国语对白做爰xxxⅹ性视频网站| 啦啦啦视频在线资源免费观看| 久久久久久久精品精品| 九色成人免费人妻av| 精品午夜福利在线看| 精品久久久久久久久亚洲| 亚洲av中文av极速乱| 中文天堂在线官网| 99国产精品免费福利视频| 久久久欧美国产精品| 久久久精品免费免费高清| 精品亚洲乱码少妇综合久久| 国产乱人偷精品视频| 日韩亚洲欧美综合| www.色视频.com| 熟女电影av网| 人人妻人人看人人澡| 一级爰片在线观看| 亚洲av不卡在线观看| 人妻少妇偷人精品九色| 国内精品宾馆在线| 王馨瑶露胸无遮挡在线观看| 精品国产三级普通话版| 久久99精品国语久久久| 1000部很黄的大片| 夫妻性生交免费视频一级片| 人妻制服诱惑在线中文字幕| 国产毛片在线视频| 日韩在线高清观看一区二区三区| 国产一级毛片在线| 啦啦啦啦在线视频资源| 中文乱码字字幕精品一区二区三区| av国产久精品久网站免费入址| 卡戴珊不雅视频在线播放| 一级片'在线观看视频| 各种免费的搞黄视频| av免费在线看不卡| 3wmmmm亚洲av在线观看| 精品国产三级普通话版| 在线观看一区二区三区| 久久精品久久久久久噜噜老黄| 亚洲欧美精品专区久久| 午夜日本视频在线| 男女啪啪激烈高潮av片| 肉色欧美久久久久久久蜜桃| 99精国产麻豆久久婷婷| 你懂的网址亚洲精品在线观看| 亚洲欧美成人精品一区二区| 国产精品国产av在线观看| 日本欧美视频一区| 欧美97在线视频| 免费人成在线观看视频色| 国产色婷婷99| 日本欧美视频一区| 新久久久久国产一级毛片| 极品少妇高潮喷水抽搐| 乱码一卡2卡4卡精品| 亚洲国产精品国产精品| 新久久久久国产一级毛片| 久热久热在线精品观看| 免费在线观看成人毛片| 国产亚洲一区二区精品| 干丝袜人妻中文字幕| 国产69精品久久久久777片| 婷婷色av中文字幕| 欧美 日韩 精品 国产| 久久久久久人妻| 国产深夜福利视频在线观看| 直男gayav资源| 国产爽快片一区二区三区| 熟妇人妻不卡中文字幕| 亚洲精品乱码久久久v下载方式| 2021少妇久久久久久久久久久| 最后的刺客免费高清国语| 高清欧美精品videossex| 国产精品嫩草影院av在线观看| 成年人午夜在线观看视频| 热99国产精品久久久久久7| 美女cb高潮喷水在线观看| 大香蕉97超碰在线| 亚洲国产色片| 99热全是精品| 80岁老熟妇乱子伦牲交| 久久99热6这里只有精品| 99热6这里只有精品| 亚洲精品成人av观看孕妇| 婷婷色av中文字幕| 中文字幕制服av| 久久精品国产a三级三级三级| 蜜桃久久精品国产亚洲av| 成年女人在线观看亚洲视频| 联通29元200g的流量卡| 久久精品熟女亚洲av麻豆精品| 成人一区二区视频在线观看| 国产精品不卡视频一区二区| 欧美高清成人免费视频www| 免费大片黄手机在线观看| 网址你懂的国产日韩在线| 日本-黄色视频高清免费观看| 婷婷色麻豆天堂久久| 精华霜和精华液先用哪个| 亚洲av.av天堂| 亚洲国产欧美在线一区| 有码 亚洲区| 久久影院123| 亚洲,一卡二卡三卡| 少妇猛男粗大的猛烈进出视频| 免费大片18禁| 男男h啪啪无遮挡| 国产亚洲精品久久久com| 成年免费大片在线观看| 久久久久久久国产电影| 午夜精品国产一区二区电影| 老熟女久久久| 精品久久久噜噜| 国产精品国产av在线观看| 99re6热这里在线精品视频| 国产成人一区二区在线| 五月开心婷婷网| 午夜福利在线观看免费完整高清在| 亚洲精品亚洲一区二区| 蜜臀久久99精品久久宅男| 精品国产三级普通话版| 黑人高潮一二区| 久久影院123| 在线观看三级黄色| 我要看日韩黄色一级片| 欧美成人a在线观看| 女性被躁到高潮视频| 欧美3d第一页| 卡戴珊不雅视频在线播放| 老司机影院成人| 亚洲欧美一区二区三区国产| 婷婷色av中文字幕| 国产精品国产三级国产专区5o| 嘟嘟电影网在线观看| 成年av动漫网址| 在线观看人妻少妇| 午夜视频国产福利| 网址你懂的国产日韩在线| 国产免费福利视频在线观看| 国产黄色免费在线视频| 少妇人妻一区二区三区视频| 丰满人妻一区二区三区视频av| 大片电影免费在线观看免费| 丰满迷人的少妇在线观看| 啦啦啦中文免费视频观看日本| 2021少妇久久久久久久久久久| 亚洲欧美一区二区三区国产| 亚洲精品乱码久久久v下载方式| 精品一品国产午夜福利视频| 内射极品少妇av片p| 不卡视频在线观看欧美| 国产男女超爽视频在线观看| 色网站视频免费| 日韩av不卡免费在线播放| 亚洲欧美精品专区久久| 亚洲欧美精品自产自拍| 日韩av在线免费看完整版不卡| 精华霜和精华液先用哪个| 777米奇影视久久| 嫩草影院新地址| 国内精品宾馆在线| 18禁动态无遮挡网站| 亚洲第一av免费看| 亚洲国产日韩一区二区| 精品熟女少妇av免费看| 婷婷色麻豆天堂久久| 美女国产视频在线观看| 丰满迷人的少妇在线观看| 亚洲欧美清纯卡通| 婷婷色av中文字幕| 久久国产精品男人的天堂亚洲 | 噜噜噜噜噜久久久久久91| 少妇裸体淫交视频免费看高清| 久久国内精品自在自线图片| 干丝袜人妻中文字幕| 久久久精品免费免费高清| 伊人久久精品亚洲午夜| 国产女主播在线喷水免费视频网站| 欧美bdsm另类| xxx大片免费视频| 久久久国产一区二区| 91在线精品国自产拍蜜月| 热99国产精品久久久久久7| 欧美极品一区二区三区四区| 99久久精品一区二区三区| 亚洲欧美日韩东京热| 亚洲色图av天堂| 国产在线免费精品| freevideosex欧美| 亚洲国产欧美在线一区| av卡一久久| 欧美丝袜亚洲另类| 国产精品女同一区二区软件| 成人免费观看视频高清| 亚洲av综合色区一区| 日产精品乱码卡一卡2卡三| 国产又色又爽无遮挡免| 国产在线一区二区三区精| 精品少妇黑人巨大在线播放| 永久免费av网站大全| 欧美bdsm另类| 亚洲精品国产成人久久av| 国产在视频线精品| 男人狂女人下面高潮的视频| av专区在线播放| 亚洲经典国产精华液单| 久久99精品国语久久久| 国产成人精品婷婷| 免费观看无遮挡的男女| a 毛片基地| 久久精品国产鲁丝片午夜精品| 亚洲人成网站在线观看播放| 亚洲经典国产精华液单| 自拍偷自拍亚洲精品老妇| 99热网站在线观看| 青青草视频在线视频观看| 人妻少妇偷人精品九色| 亚洲不卡免费看| 国产午夜精品一二区理论片| 亚洲成人av在线免费| 在线观看免费日韩欧美大片 | 婷婷色综合大香蕉| 两个人的视频大全免费| av在线蜜桃| 久久久亚洲精品成人影院| 日韩av在线免费看完整版不卡| 搡女人真爽免费视频火全软件| 国产精品精品国产色婷婷| av不卡在线播放| 国产精品一二三区在线看| 美女中出高潮动态图| 九九在线视频观看精品| 久久99蜜桃精品久久| 一边亲一边摸免费视频| 狂野欧美激情性bbbbbb| 人人妻人人看人人澡| 国产黄频视频在线观看| 久久人人爽av亚洲精品天堂 | 一个人看的www免费观看视频| 国产成人免费观看mmmm| 性色avwww在线观看| 99久久精品国产国产毛片| 亚洲av在线观看美女高潮| 直男gayav资源| 伊人久久精品亚洲午夜| 亚洲精品日韩在线中文字幕| 国产男人的电影天堂91| 亚洲精品日本国产第一区| 国产欧美日韩一区二区三区在线 | 亚洲第一区二区三区不卡| 欧美日韩精品成人综合77777| 在线观看国产h片| 亚洲欧美中文字幕日韩二区| videos熟女内射| 伦理电影大哥的女人| 日本免费在线观看一区| 国产精品成人在线| 成人18禁高潮啪啪吃奶动态图 | 午夜视频国产福利| 亚洲成人av在线免费| 亚洲欧洲国产日韩| av国产精品久久久久影院| 久久久色成人| 久久精品国产鲁丝片午夜精品| 精品酒店卫生间| 亚洲精品久久久久久婷婷小说| 精品久久国产蜜桃| 中文乱码字字幕精品一区二区三区| 亚洲va在线va天堂va国产| 观看免费一级毛片| 交换朋友夫妻互换小说| 精品久久久久久电影网| 国产免费视频播放在线视频| 韩国高清视频一区二区三区| 国产成人精品一,二区| 在线天堂最新版资源| 91午夜精品亚洲一区二区三区| 国产精品秋霞免费鲁丝片| 少妇裸体淫交视频免费看高清| 最近2019中文字幕mv第一页| 免费少妇av软件| 国产熟女欧美一区二区| 我的女老师完整版在线观看| 王馨瑶露胸无遮挡在线观看| 99久久人妻综合| 日本欧美视频一区| 在线精品无人区一区二区三 | av又黄又爽大尺度在线免费看| 18禁在线播放成人免费| 在线 av 中文字幕| 少妇精品久久久久久久| 一区二区三区精品91| www.色视频.com| 高清不卡的av网站| 国产无遮挡羞羞视频在线观看| 日日摸夜夜添夜夜添av毛片| 亚洲精品视频女| 有码 亚洲区| 国产成人aa在线观看| 国产伦精品一区二区三区四那| 国产精品久久久久久久电影| 少妇人妻久久综合中文| 男男h啪啪无遮挡| 中文字幕免费在线视频6| 国产精品不卡视频一区二区| freevideosex欧美| 青春草亚洲视频在线观看| 国产精品国产三级国产专区5o| 免费看不卡的av| 国产一区二区三区av在线| 十分钟在线观看高清视频www | av在线app专区| 亚洲第一av免费看| 我的老师免费观看完整版| av又黄又爽大尺度在线免费看| 最后的刺客免费高清国语| 涩涩av久久男人的天堂| 一级毛片黄色毛片免费观看视频| 一区二区av电影网| 久久久久人妻精品一区果冻| 久久99热6这里只有精品| 18+在线观看网站| 观看av在线不卡| 久久国产亚洲av麻豆专区| 啦啦啦啦在线视频资源| 亚洲国产日韩一区二区| 又大又黄又爽视频免费| 卡戴珊不雅视频在线播放| av黄色大香蕉| 国产精品一区二区性色av| 免费久久久久久久精品成人欧美视频 | 久久婷婷青草| 日本黄大片高清| 高清av免费在线| 丝袜脚勾引网站| 久久国产精品大桥未久av | 18禁裸乳无遮挡动漫免费视频| 免费观看的影片在线观看| 人妻制服诱惑在线中文字幕| 国产国拍精品亚洲av在线观看| 熟妇人妻不卡中文字幕| 汤姆久久久久久久影院中文字幕| 久久国内精品自在自线图片| 九草在线视频观看| av一本久久久久| 一个人免费看片子| 婷婷色综合大香蕉| 国产精品99久久99久久久不卡 | 国产老妇伦熟女老妇高清| 国产女主播在线喷水免费视频网站| 国内精品宾馆在线| 欧美精品一区二区大全| 秋霞在线观看毛片| 久久99精品国语久久久| 中文字幕亚洲精品专区| 日日撸夜夜添| 精品一品国产午夜福利视频| 一级二级三级毛片免费看| 不卡视频在线观看欧美| videossex国产| 免费观看av网站的网址| 51国产日韩欧美| 国产精品福利在线免费观看| 免费黄网站久久成人精品| 日日撸夜夜添| 久久精品国产鲁丝片午夜精品| 国内揄拍国产精品人妻在线| 极品少妇高潮喷水抽搐| 国产男女内射视频| 国产伦在线观看视频一区| av在线播放精品| 国产黄片美女视频| 一本一本综合久久| 国产极品天堂在线| 狠狠精品人妻久久久久久综合| 亚洲国产精品专区欧美| 久久精品熟女亚洲av麻豆精品| 亚洲精品国产成人久久av| 国产精品99久久久久久久久| 久久午夜福利片| 欧美xxⅹ黑人| 免费在线观看成人毛片| 最新中文字幕久久久久| 99热这里只有是精品50| 久久ye,这里只有精品| 国产成人freesex在线| 美女内射精品一级片tv| 两个人的视频大全免费| 国产69精品久久久久777片| 久久精品国产自在天天线| av黄色大香蕉| 夫妻午夜视频| 久久精品国产亚洲av涩爱| 亚洲成人手机| 1000部很黄的大片| 啦啦啦啦在线视频资源| 精品久久久久久电影网| 成人一区二区视频在线观看| 91久久精品国产一区二区成人| 女人久久www免费人成看片| 国产在视频线精品| 男女边摸边吃奶| 免费看日本二区| 久久久成人免费电影| 成人综合一区亚洲| 天堂8中文在线网| 久久女婷五月综合色啪小说| av女优亚洲男人天堂| 在线观看免费日韩欧美大片 | 青春草国产在线视频| 3wmmmm亚洲av在线观看| 亚洲av成人精品一区久久| 91久久精品国产一区二区三区| 免费看光身美女| 一级毛片我不卡| 国内少妇人妻偷人精品xxx网站| 妹子高潮喷水视频| 国产精品一及| 人人妻人人看人人澡| 亚洲,一卡二卡三卡| 夜夜看夜夜爽夜夜摸| 51国产日韩欧美| 3wmmmm亚洲av在线观看| 国产免费又黄又爽又色| 欧美一区二区亚洲| 精品国产露脸久久av麻豆| 国产黄色视频一区二区在线观看| 久久精品国产自在天天线| 国产精品麻豆人妻色哟哟久久| 亚洲国产欧美人成| 色哟哟·www| a级一级毛片免费在线观看| 精品久久久久久久久av| 精品一品国产午夜福利视频| 97在线视频观看| 青青草视频在线视频观看| av专区在线播放| 男女边吃奶边做爰视频| 久久久欧美国产精品| 综合色丁香网| 岛国毛片在线播放| 丰满少妇做爰视频| 国产精品久久久久久久电影| 久久久久网色| 精品熟女少妇av免费看| 2021少妇久久久久久久久久久| 美女脱内裤让男人舔精品视频| 亚洲国产欧美人成| 国产又色又爽无遮挡免| 深爱激情五月婷婷| 国产成人精品福利久久| 99久久综合免费| 美女脱内裤让男人舔精品视频| 久久97久久精品| 亚洲最大成人中文| 一级毛片久久久久久久久女| 人妻一区二区av| 国产综合精华液| 免费av不卡在线播放| 国产黄色视频一区二区在线观看| 国内揄拍国产精品人妻在线| 99久久精品一区二区三区| 高清不卡的av网站| 91久久精品电影网| 极品教师在线视频| 久久人人爽人人爽人人片va| 国产一区二区三区综合在线观看 | 伊人久久精品亚洲午夜| 久久国内精品自在自线图片| 亚洲av欧美aⅴ国产| 水蜜桃什么品种好| 亚洲精品自拍成人| 久久人人爽人人片av| 日日啪夜夜撸| 天堂俺去俺来也www色官网| 少妇被粗大猛烈的视频| 国产日韩欧美亚洲二区| 97超视频在线观看视频| 久久婷婷青草| 国产精品女同一区二区软件| 五月开心婷婷网| 最近手机中文字幕大全| 中文天堂在线官网| 久久99热6这里只有精品| 日韩中字成人| 丝瓜视频免费看黄片| 我的女老师完整版在线观看| 精品视频人人做人人爽| 一级二级三级毛片免费看| 久久久久国产网址| 99九九线精品视频在线观看视频| 国产探花极品一区二区| 日本爱情动作片www.在线观看| 黄色一级大片看看| 亚洲va在线va天堂va国产| 日本黄大片高清| 欧美精品亚洲一区二区| 日产精品乱码卡一卡2卡三| 国产中年淑女户外野战色| 成人毛片a级毛片在线播放| 久久人人爽人人片av| 欧美精品一区二区免费开放| 国产无遮挡羞羞视频在线观看| 少妇人妻一区二区三区视频| 婷婷色av中文字幕| 日韩中字成人| av线在线观看网站| 99久久中文字幕三级久久日本| 欧美成人午夜免费资源| 亚洲美女视频黄频| 国产久久久一区二区三区| 午夜日本视频在线| 毛片女人毛片| 亚洲欧美一区二区三区黑人 | 亚洲av中文av极速乱| 99热全是精品| 日本色播在线视频| 熟妇人妻不卡中文字幕| 日韩制服骚丝袜av| 中文字幕人妻熟人妻熟丝袜美| 午夜激情久久久久久久| 女性生殖器流出的白浆| 免费黄色在线免费观看| 18禁裸乳无遮挡动漫免费视频| 国产成人freesex在线| 黄色视频在线播放观看不卡| 亚洲国产精品专区欧美| 欧美人与善性xxx| 在线免费十八禁| 日本wwww免费看| 91狼人影院| 国产精品嫩草影院av在线观看| 哪个播放器可以免费观看大片| av专区在线播放| 日韩欧美精品免费久久| 欧美日韩视频精品一区| 男人添女人高潮全过程视频| 天天躁日日操中文字幕| 国产黄频视频在线观看| 联通29元200g的流量卡| 久久午夜福利片| 国产真实伦视频高清在线观看| 青春草视频在线免费观看| 亚洲成人手机| 亚洲美女黄色视频免费看| 在线观看免费视频网站a站| 欧美日韩国产mv在线观看视频 | 精品亚洲成a人片在线观看 | 在线看a的网站| 亚洲图色成人| 在线观看美女被高潮喷水网站| 1000部很黄的大片| 国产乱人偷精品视频| 视频中文字幕在线观看| 天天躁夜夜躁狠狠久久av| 最近最新中文字幕大全电影3| 日本av手机在线免费观看| 在线观看av片永久免费下载| 久久久久久久久久久丰满| 久久久久人妻精品一区果冻| 三级国产精品欧美在线观看| 国产在线一区二区三区精| 少妇裸体淫交视频免费看高清| 在线观看av片永久免费下载|